Assignment of Assignor's Interest

Recorded: 2014-10-22 Pages: 20

Assignor

OSIRIS THERAPEUTICS, INC.

Executed: 2013-10-10

Assignee

MESOBLAST INTERNATIONAL SARL

ROUTE DE PRE-BOIS 20, MEYRIN, 1217, SWITZERLAND

Covered Properties (2)

Mesenchymal Stem Cells Expressing TNF-alpha Receptors

Application: 14/228,327 →

Publication: US 2014/0248244

Mesenchymal Stem Cells Expressing TNF-alpha Receptors

Application: 14/484,444 →

Publication: US 2015/0004693

Related Assignments (1)

Other recorded transfers of the patents in this record — the chain of ownership.